DCF — ST. LUKES NAMPA MEDICAL CENTER
Enterprise Value: $-407.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-407.5M
Enterprise Value
$-129.2M
PV of Cash Flows
$-278.3M
PV of Terminal Value
$-448.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $263.3M | $-25.2M | -10.0% | $-36.4M | $-33.1M |
| Year 2 | $271.2M | $-23.3M | -9.0% | $-34.8M | $-28.7M |
| Year 3 | $279.3M | $-21.2M | -8.0% | $-33.0M | $-24.8M |
| Year 4 | $287.7M | $-20.4M | -7.0% | $-32.6M | $-22.2M |
| Year 5 | $296.4M | $-20.3M | -7.0% | $-32.8M | $-20.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-407.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$255.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.10083966852791124
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5